pharma · Metastatic Prostate Cancer · Prostate Cancer · TLX
Telix Innovations
Telix Innovations trial registry — 28 ClinicalTrials.gov studies with program phase, status, and indication context.
Rue de Hermée 255, Herstal, Région wallonne 4040, BE HQ
2015 Founded
14 Employees
Public company Type
TLX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Rue de Hermée 255, Herstal, Région wallonne 4040, BE
- Founded
- 2015
- Employees
- 14
- Programs
- 27
- Drugs
- 11
- Patents
- 3
Telix Innovations clinical trials
Registry index of 28 ClinicalTrials.gov studies linked to Telix Innovations programs — each row shows trial ID, program name, phase, status, and indication.
Telix Innovations trial registry — 28 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Telix Innovations.
-
PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC — Phase 2
Clinical update -
Zirconium Zr 89 Girentuximab — Phase 2
Clinical update -
Ga-68-PSMA-11 — Phase 3
Clinical update -
Fluciclovine F18 — Phase 2
Clinical update -
68Ga-PSMA-11 — Phase 3
Clinical update -
177Lu girentuximab — Phase 2
Clinical update -
Standard of Care — Phase 3
Clinical update -
177Lu-TLX250 — Phase 3
Clinical update